ConductScience.org, home

Paper2249335

7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.

Borsi JD and 4 others. Cancer Chemother Pharmacol, 1990. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia. Papers, record 2249335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2249335

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.48
iCite
Revised in PubMed
2019-08-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Borsi JDJ D
2Sagen EE
3Romslo II
4Slørdal LL
5Moe PJP J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Folic Acid AntagonistsMajor topic
MethotrexateMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Aging
Antineoplastic Agents
Child
Child, Preschool
Humans
Infant
Infusions, Intravenous
Prognosis

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13467178[New aspects of the determination of blood methotrexate levels in leukemic children].Monatsschr Kinderheilkd1986https://conductscience.org/library/papers/3467178PubMed
26600662Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6600662PubMed
310623837-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.J Clin Invest1976https://conductscience.org/library/papers/1062383PubMed
42414788The cellular pharmacology of methotrexate.Pharmacol Ther1985https://conductscience.org/library/papers/2414788PubMed
56715337Synthesis and properties of 7-hydroxymethotrexate polyglutamyl derivatives in Ehrlich ascites tumor cells in vitro.J Biol Chem1984https://conductscience.org/library/papers/6715337PubMed
66692419Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro.Cancer Res1984https://conductscience.org/library/papers/6692419PubMed
77251770Rapid and simple method for the measurement of methotrexate and 7-hydroxymethotrexate in serum by high-performance liquid chromatography.J Chromatogr1981https://conductscience.org/library/papers/7251770PubMed
83456079Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.N Engl J Med1986https://conductscience.org/library/papers/3456079PubMed
96141424Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia.Lancet1984https://conductscience.org/library/papers/6141424PubMed
107189691The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy.Cancer Lett1980https://conductscience.org/library/papers/7189691PubMed
116883624Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6883624PubMed
123472638A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.Cancer1987https://conductscience.org/library/papers/3472638PubMed
133479231Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children.Cancer1987https://conductscience.org/library/papers/3479231PubMed
14720376Pharmacokinetics of high-dose methotrexate treatment in children.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/720376PubMed
153472677Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3472677PubMed
166956440Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.Cancer Treat Rep1982https://conductscience.org/library/papers/6956440PubMed
176971042Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.Acta Paediatr Scand1981https://conductscience.org/library/papers/6971042PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2249335

GET https://conductscience.org/api/papers/v1/2249335/authors